AAAAAA
Results:
1-19
|
Results: 19
Authors:
Temsamani, J
Rousselle, C
Rees, AR
Scherrmann, JM
Citation: J. Temsamani et al., Vector-mediated drug delivery to the brain, EXPERT OP B, 1(5), 2001, pp. 773-782
Authors:
Mazel, M
Clair, P
Rousselle, C
Vidal, P
Scherrmann, JM
Mathieu, D
Temsamani, J
Citation: M. Mazel et al., Doxorubicin-peptide conjugates overcome multidrug resistance, ANTI-CANC D, 12(2), 2001, pp. 107-116
Authors:
Cisternino, S
Rousselle, C
Dagenais, C
Scherrmann, JM
Citation: S. Cisternino et al., Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice, PHARM RES, 18(2), 2001, pp. 183-190
Authors:
Rousselle, C
Smirnova, M
Clair, P
Lefauconnier, JM
Chavanieu, A
Calas, B
Scherrmann, JM
Temsamani, J
Citation: C. Rousselle et al., Enhanced delivery of doxorubicin into the brain via a peptide-vector-mediated strategy: Saturation kinetics and specificity, J PHARM EXP, 296(1), 2001, pp. 124-131
Authors:
Hong, GY
Chappey, O
Niel, E
Scherrmann, JM
Citation: Gy. Hong et al., Enhanced cellular uptake and transport of polyclonal immunoglobulin G and Fab after their cationization, J DRUG TAR, 8(2), 2000, pp. 67-77
Authors:
Decleves, X
Regina, A
Laplanche, JL
Roux, F
Boval, B
Launay, JM
Scherrmann, JM
Citation: X. Decleves et al., Functional expression of P-glycoprotein and multidrug resistance-associated protein (Mrp1) in primary cultures of rat astrocytes, J NEUROSC R, 60(5), 2000, pp. 594-601
Authors:
Dagenais, C
Rousselle, C
Pollack, GM
Scherrmann, JM
Citation: C. Dagenais et al., Development of an in situ mouse brain perfusion model and its application to mdr1a P-glycoprotein-deficient mice, J CEREBR B, 20(2), 2000, pp. 381-386
Authors:
Boschi, G
Scherrmann, JM
Citation: G. Boschi et Jm. Scherrmann, Microdialysis in mice for drug delivery research, ADV DRUG DE, 45(2-3), 2000, pp. 271-281
Authors:
Rousselle, C
Clair, P
Lefauconnier, JM
Kaczorek, M
Scherrmann, JM
Temsamani, J
Citation: C. Rousselle et al., New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy, MOLEC PHARM, 57(4), 2000, pp. 679-686
Authors:
Scherrmann, JM
Citation: Jm. Scherrmann, Biodynamics of antigen-antibody reaction in vivo, B ACA N MED, 184(3), 2000, pp. 637-649
Authors:
Coudereau, JP
Stain, F
Drion, N
Sandouk, P
Monier, C
Debray, M
Scherrmann, JM
Bourre, JM
Frances, H
Citation: Jp. Coudereau et al., Effect of social isolation on the metabolism of morphine and its passage through the blood-brain barrier and on consumption of sucrose solutions, PSYCHOPHAR, 144(3), 1999, pp. 198-204
Authors:
Pham-Huy, C
Stathoulopoulou, F
Sandouk, P
Scherrmann, JM
Palombo, S
Girre, C
Citation: C. Pham-huy et al., Rapid determination of valaciclovir and acyclovir in human biological fluids by high-performance liquid chromatography using isocratic elution, J CHROMAT B, 732(1), 1999, pp. 47-53
Authors:
Weinling, E
Sandouk, P
Debray, M
Scherrmann, JM
Citation: E. Weinling et al., Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers, INT J CL PH, 37(10), 1999, pp. 503-509
Authors:
Got, P
Raimbaud, E
Bussey, C
Caron, G
Carrupt, PA
Walther, B
Bensussan, A
Scherrmann, JM
Citation: P. Got et al., Production and characterization of 22 monoclonal antibodies directed against S 20499, a new potent 5-HT1A chiral agonist: Influence of the hapten structure on specificity and stereorecognition, PHARM RES, 16(5), 1999, pp. 725-735
Authors:
Renard, C
Weinling, E
Pau, B
Scherrmann, JM
Citation: C. Renard et al., Time- and dose-dependent digoxin redistribution by digoxin-specific antigen binding fragments in a rat model, TOXICOLOGY, 137(2), 1999, pp. 117-127
Authors:
Renard, C
Chappey, O
Wautier, MP
Nagashima, M
Morser, J
Scherrmann, JM
Wautier, JL
Citation: C. Renard et al., The human and rat recombinant receptors for advanced glycation end products have a high degree of homology but different pharmacokinetic properties in rats, J PHARM EXP, 290(3), 1999, pp. 1458-1466
Authors:
Girod, J
Fenart, L
Regina, A
Dehouck, MP
Hong, GY
Scherrmann, JM
Cecchelli, R
Roux, F
Citation: J. Girod et al., Transport of cationized anti-tetanus Fab ' 2 fragments across an in vitro blood-brain barrier model: Involvement of the transcytosis pathway, J NEUROCHEM, 73(5), 1999, pp. 2002-2008
Authors:
Stain-Texier, F
Boschi, G
Sandouk, P
Scherrmann, JM
Citation: F. Stain-texier et al., Elevated concentrations of morphine 6-beta-D-glucuronide in brain extracellular fluid despite low blood-brain barrier permeability, BR J PHARM, 128(4), 1999, pp. 917-924
Authors:
Goudemand, J
Peynet, J
Chambost, H
Negrier, C
Briquel, ME
Claeyssens, S
Derlon-Borel, A
Guerois, C
Caron, C
Scherrmann, JM
Debray, M
Bridey, F
Citation: J. Goudemand et al., A cross-over pharmacokinetic study of a double viral inactivated factor IXconcentrate (15 nm filtration and SD) compared to a SD factor IX concentrate, THROMB HAEM, 80(6), 1998, pp. 919-924
Risultati:
1-19
|